Ordinary life for extraordinary people

"We knew we wanted to be a medical device company from day one, and we built Wandercraft into one. The technological prowess is what amazes everyone at the first glance, but it is what this prowess achieves that really drives us: offering the best therapeutical solution both for patients and their therapists. Wandercraft will not stop until every patients get the rehabilitation and autonomy he deserves"
Mathieu Masselin, CEO2010 - 2016
In 2010, Nicolas Simon was chairman of the robotics club at the Ecole Polytechnique in Paris. Having very close relatives with walk impairment, he started working on one of the Holy Grails of robotics: how to get a biped robot to walk like a human, in a self-stabilized manner. At the time, and still today, only a handful of walking robots are capable of realistic humanoid walk - and all are expensive, one-of-a-kind prototypes. Nicolas designed the first concept for a real-life exoskeleton that would truly walk. He founded Wandercraft in 2012 with two classmate roboticists, Alexandre Boulanger, soon joined by Matthieu Masselin, now Wandercraft’s CEO. They were assisted by a serial entrepreneur and father of a walking impaired boy, Jean-Louis Constanza, who joined the operating team a few years later. The founders gradually gathered a team of scientists and engineers around one mission: leveraging state of the art dynamic walk robotics to help walking impaired people regain mobility. Step by step, the WanderTeam integrated robotic dynamic walk algorithms into a lower limb exoskeleton capable of emulating human self-balanced walk.


“The team is everything. We strive to attract the A players in each field we invest into. We pride ourselves as being the best walk robotic team in the exoskeleton industry. We value scientific excellence which is why we partner with the best academic teams such as Jessy Grizzle's at Umich and Aaron Ames' at Caltech.”
Nicolas Simon, Chairman of the board
2017 - Today
In 2017, we conducted world premiere clinical trials with the first protoypes of the exo, showing that paraplegic persons could walk hands-free, without crutches. The proof of concept device evolved into Atalante, our first commercial exoskeleton, that was CE marked in 2019. Atalante is used today in a rapidly growing number of European rehabilitation hospitals and helps stroke or SCI patients in gait re-learning. We are working hard on expanding outside Europe. Research exoskeletons have already been sold in the US and FDA submission is planned for 2021.

“Our investors are essential members of the team. We work on the forefront of both robotics and medicine, our business requires those rare investors who understand healthcare, deep tech and hard tech. In exchange for their vision and advice, we provide them with real-time, exhaustive information.”
Jean-Louis Constanza, Chief Business
Leadership team
Wandercraft gradually attracted experienced managers who helped us grow from a start-up company to an industrial player
Wanderteam

Join the revolution
You wish to upgrade your facility with Atalante?Contact us. We will be happy to call you back.
contact@wandercraft.eu
+33 (0)9 72 58 77 05
88 rue de Rivoli-75004 PARIS
Monday to Friday
from 8:30 am to 6:00 pm
Copyright 2020, Wandercraft